Immunological mechanisms of epidermal damage in toxic epidermal necrolysis

被引:27
|
作者
Tohyama, Mikiko [1 ]
Hashimoto, Koji [1 ]
机构
[1] Ehime Univ, Dept Dermatol, Grad Sch Med, Toon City, Ehime 7910295, Japan
关键词
apoptosis-inducing factor; cytotoxic lymphocyte; macrophage; monocyte; toxic epidermal necrolysis; STEVENS-JOHNSON-SYNDROME; REGULATORY T-CELLS; SOLUBLE FAS LIGAND; EFFECTOR-CELLS; GRANULYSIN; EXPRESSION; 4-1BB; APOPTOSIS; ALPHA; CYCLOSPORINE;
D O I
10.1097/ACI.0b013e328355b865
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review The purpose of the present review is to introduce recent findings on the pathomechanisms of toxic epidermal necrolysis (TEN), which is characterized by widespread epidermal detachment due to keratinocyte apoptosis. Recent findings In the mechanism of epidermal damage, the roles of drug metabolites, cytotoxic lymphocytes, and apoptosis-inducing factors have been noted. In addition, recent studies have focused on monocytes/macrophages, which may participate in epidermal damage through the production of apoptosis-inducing factors and the expression of costimulatory factors with the ability to activate CD8(+) T cells. Summary Epidermal keratinocyte death is a hallmark of TEN. In a very high proportion of cases, drugs are responsible for TEN. It has been suggested that toxic drug metabolites produced by keratinocytes act like electrophilic agents to induce apoptosis and inflammation. Next, cytotoxic lymphocytes and monocytes function in the development of widespread epidermal damage through direct or indirect cytotoxic pathways. In addition, T-cell activation may be strengthened by the impairment of regulatory T-cell function and activated monocytes. The development of epidermal damage in TEN may require the coordinated action of these factors.
引用
收藏
页码:376 / 382
页数:7
相关论文
共 50 条
  • [1] A Review of the Pathogenesis of Toxic Epidermal Necrolysis
    Kinoshita, Yuri
    Saeki, Hidehisa
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2016, 83 (06) : 216 - 222
  • [2] Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis
    Abe, Riichiro
    JOURNAL OF DERMATOLOGY, 2015, 42 (01) : 42 - 48
  • [3] Facing up to toxic epidermal necrolysis
    Pierard, Gerald E.
    Paquet, Philippe
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (15) : 2443 - 2446
  • [4] Review of Toxic Epidermal Necrolysis
    Harris, Victoria
    Jackson, Christopher
    Cooper, Alan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12):
  • [5] Toxic epidermal necrolysis
    Hinc-Kasprzyk, Joanna
    Polak-Krzeminska, Agnieszka
    Ozog-Zabolska, Irena
    ANAESTHESIOLOGY INTENSIVE THERAPY, 2015, 47 (03) : 257 - 262
  • [6] Toxic epidermal necrolysis: the year in review
    Lee, Haur-Yueh
    Chung, Wen-Hung
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 13 (04) : 330 - 336
  • [7] Etanercept therapy for toxic epidermal necrolysis
    Paradisi, Andrea
    Abeni, Damiano
    Bergamo, Fabio
    Ricci, Francesco
    Didona, Dario
    Didona, Biagio
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (02) : 278 - 283
  • [8] Pharmacogenetics of toxic epidermal necrolysis
    Lee, Ming Ta Michael
    Hung, Shuen-Iu
    Wei, Chun-Yu
    Chen, Yuan-Tsong
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (13) : 2153 - 2162
  • [9] Toxic epidermal necrolysis
    Le Cleach, L
    Roujeau, JC
    JOURNAL OF DERMATOLOGICAL TREATMENT, 1998, 9 (01) : 35 - 37
  • [10] TOXIC EPIDERMAL NECROLYSIS
    ROHRER, TE
    AHMED, AR
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1991, 30 (07) : 457 - 466